Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domain
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Laurène Adam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden. Hauptthemen laut MEDLINE: alpha-Synuclein, Molecular Chaperones, Protein Aggregates. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Åke Wiberg Foundation, Brain Foundation, Forskningsrådet Formas.
Abstract (Originalsprache)
Current therapeutic approaches for Parkinson's disease and other synucleinopathies alleviate symptoms but fail to effectively prevent disease progression. As a result, there is an increasing focus on alternative disease-modifying strategies where molecular chaperones are emerging candidates. Recently, the chaperone-like Bri2 BRICHOS domain has been shown to be a promising therapeutic candidate, inhibiting amyloid formation and associated toxicity of multiple amyloidogenic proteins including human α-synuclein (αSyn). To advance the development of Bri2 BRICHOS as a therapeutic, in vivo tests in mice are necessary, which commonly rely on the injections of preformed fibrils of mouse αSyn. Here, we investigate the inhibitory mechanism of Bri2 BRICHOS on mouse αSyn aggregation and fibril interaction. In contrast to previous results on human αSyn, we found that Bri2 BRICHOS exhibits a very modest inhibitory effect on mouse αSyn aggregation, which is only observed under gentle shaking or quiescent conditions. While Bri2 BRICHOS binds with similar affinities to the respective fibrils, we observed that differences in the underlying nucleation mechanisms of mouse versus human αSyn fibril formation explain the impaired suppression of mouse αSyn fibrillation under strong shaking conditions. The more fragile nature of mouse αSyn fibrils causes stronger contributions of fibril fragmentation processes compared to surface-catalyzed secondary nucleation-the dominant nucleation mechanism for human αSyn. In conclusion, these findings provide molecular insights into the mechanism-of-action of Bri2 BRICHOS-mediated inhibition of αSyn aggregation as a selective chaperone-based inhibitor of surface-catalyzed secondary nucleation pathways, which facilitates informed choices of in vivo model systems for future treatment studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden.
- Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark.
- Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark; Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
- Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden. Electronic address: axel.abelein@ki.se.
Förderung
- Åke Wiberg Foundation
- Brain Foundation
- Forskningsrådet Formas
- Alzheimer Fund
- Magnus Bergvall Foundation
- Svenska Forskningsrådet Formas
- Center for Innovative Medicine
- Maja & JP Åhlén Foundation
Zitieren
APA
Adam, L., Molenkamp, W. H., Nowak, J. S., Farzadfard, A., Gaarthuis, K., Kumar, R., Nielsen, J., Otzen, D. E., Johansson, J., & Abelein, A. (2026). Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domain. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113117
Vancouver
Adam L, Molenkamp WH, Nowak JS, Farzadfard A, Gaarthuis K, Kumar R, et al. Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domain. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113117
BibTeX
@article{Adam2026,
author = {Adam, Laurène and Molenkamp, Willem Hendrik and Nowak, Jan Stanislaw and Farzadfard, Azad and Gaarthuis, Koen and Kumar, Rakesh and Nielsen, Janni and Otzen, Daniel E and Johansson, Jan and Abelein, Axel},
title = {Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domain},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113117}
}
EUVIMED